Canadian families stunned by 3,000% increase in price of life-saving drug

12 March 2018 - Drug for patients with cystinosis being replaced by new form with same active ingredient. ...

Read more →

New Patented Medicine Prices Review Board Chairperson announced

17 February 2018 - Dr. Mitchell Levine appointed as Chairperson of the Patented Medicine Prices Review Board. ...

Read more →

Canadian patient groups call on Federal Health Minister to halt the process examining proposed amendments to the Patented Medicine Regulations pending constructive consultations

15 February 2018 - Patient feedback has not been considered – groups seek meaningful dialogue with Government and drug manufactures ...

Read more →

Canadian generic drug prices higher than international levels in recent years

6 February 2018 - The Patented Medicine Prices Review Board releases its latest report on generic drug pricing in Canada. ...

Read more →

The real story behind the sudden drop in Canada's drug prices

3 February 2018 - And is Ontario offering a college diploma in 'pseudoscience?' ...

Read more →

To avoid open bidding, generic-drug makers cut prices outside Quebec

30 January 2018 - The provinces outside Quebec are expecting to save as much as $3-billion over five years after ...

Read more →

At $262.40 per pill, the cancer drug that could save her life isn’t covered in B.C.

19 January 2018 - Karen McLaren of Langley has stage four breast cancer, and has been prescribed a drug that could ...

Read more →

How Ottawa's using a fake drug crisis to force through damaging pharmaceutical policy

16 January 2018 - There is no affordability crisis to justify expanding drug price regulation, or a new national government-run pharmacare ...

Read more →

Canada's regulator of patented drug prices is rigging data, and risking our health

5 December 2017 - The patent medicine pricing board is making a blatant attempt to bias the data. ...

Read more →

Prescription drug costs should be fair – not cheap

4 December 2017 - "Canadians are not getting the value for money on prescription medicine spending or the outcomes they ...

Read more →

Ottawa unveils new draft regulations for drug-pricing

2 December 2017 - The Trudeau government is plowing ahead with an overhaul of the country's drug-pricing rules, unveiling draft ...

Read more →

Drug firms warn Ottawa against ‘crippling’ price cuts

31 October 2017 - Canada's brand-name pharmaceutical companies are pushing back against a plan to overhaul Canada's drug-pricing regulator, saying ...

Read more →

Study finds significant overlap in the drugs covered by Canadian public drug plans

11 October 2017 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilisation Information System research initiative, ...

Read more →

Blacked-out information reveals secret world of drug prices

30 September 2017 - This week, the Patented Medicine Prices Review Board ruled the Canadian price of the drug Soliris is ...

Read more →

Canadian regulator orders price cut of expensive U.S. drug Soliris

27 September 2017 - The maker of the one of the world's most expensive drugs has been ordered to slash ...

Read more →